DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 52 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $797,000 | +60.0% | 36,193 | +4.3% | 0.04% | +56.0% |
| Q3 2019 | $498,000 | +32.8% | 34,693 | +13.2% | 0.02% | +66.7% |
| Q2 2018 | $375,000 | +271.3% | 30,646 | +73.6% | 0.02% | +200.0% |
| Q3 2017 | $101,000 | +215.6% | 17,650 | +56.8% | 0.01% | +150.0% |
| Q4 2016 | $32,000 | -81.2% | 11,256 | -80.2% | 0.00% | -75.0% |
| Q2 2016 | $170,000 | -79.1% | 56,763 | -2.8% | 0.01% | -70.4% |
| Q2 2015 | $814,000 | +22.2% | 58,398 | +110.5% | 0.03% | +17.4% |
| Q1 2015 | $666,000 | – | 27,748 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |